arrow
D

Debbie S. Gipson

West Virginia University
H指数:67
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today
2024-02-014
OAAI
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study
2024-01-014
OAAI
Clustering-based spatial analysis (CluSA) framework through graph neural network for chronic kidney disease prediction using histopathology images
2023-08-056
OAAI
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network
2023-06-013
OAAI
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
2023-03-0129
OA
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes

高危APOL1基因型患者局灶节段性肾小球硬化的快速进展

2023-02-089
OA
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific orkshop Sponsored by the National Kidney Foundation

改善补体介导的肾小球疾病中抗补体疗法的临床试验: 国家肾脏基金会赞助的科学orkshop的报告

2022-04-0112
PRE
Unsupervised machine learning for identifying important visual features through bag-of-words using histopathology data from chronic kidney disease
2022-03-2221
OAAI
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
2021-10-016
PREAI
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy TRACTION-2 Trial Design
2021-10-0125
OAAI